Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Neuropace, Inc. (NPCE)

NASDAQ

$14.23

$-0.37

(-2.54%)

Pre-Market

Neuropace, Inc. (NPCE) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Neuropace, Inc. (NPCE) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $14.23, with a market capitalisation of $500.79M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.22 to $19.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$500.79M
Open	$14.48
Day's High	$27.38
Day's Low	$1.22
Previous Close	$14.59
Volume	80.63K
Average Volume	185.66K
P/E Ratio	--
52-Week High	$19.60
52-Week Low	$9.22
Dividend Yield	--
Earnings Date	--

Neuropace, Inc. (NPCE) Pre-Market Stock Price

Neuropace, Inc. (NPCE) is trading at $14.60 in pre-market trading as of 2026-09-15 23:31:00, up 0.07% ($0.01) from the previous close of $14.59

Pre-market trading shows how investors are pricing NPCE before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Neuropace, Inc. (NPCE) 7-Day Stock Price Change

Over the past seven days, Neuropace, Inc. (NPCE) moved from $14.90 to $14.23, representing a decline of 4.48% ($0.67).

The stock traded between $13.82 and $15.10 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 97.05 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

NPCE 52-Week Price Position

Position in Range: 48.3%

52W Low$9.22

52W High$19.60

NPCE is currently trading at $14.23, placing it 48.3% of the way from its 52-week low of $9.22 to its 52-week high of $19.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Neuropace, Inc. (NPCE)?

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Neuropace, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	220
Exchange	NASDAQ
Company Website	https://www.neuropace.com

How to Buy Neuropace, Inc. (NPCE) Stock on MEXC

Eligible investors can buy real shares of Neuropace, Inc. (NPCE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NPCE and Place Your Order

Open the RealStocks trading page and search for NPCE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Neuropace, Inc. (NPCE) stock price today?

Neuropace, Inc. (NPCE) is currently trading at $ 14.23, down 2.45% ($0.36) from the previous close of $ 14.59. Intraday prices update in real time during regular trading hours.

2.Is NPCE stock going up or down today?

As of 2026-09-15 23:31:00, NPCE is trading at $ 14.23, down 2.45% ($0.36) from its previous close of $ 14.59. The stock has traded between $ 1.22 and $ 27.38 during today’s regular session. Past price movements do not guarantee future results.

3.What is NPCE pre-market price?

As of 2026-09-15 23:31:00, NPCE is trading at $ 14.60 in pre-market trading, up 0.07% ($0.01) from the previous close of $ 14.59. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NPCE after-hours price?

As of 2026-09-15 23:31:00, NPCE is trading at $ 14.25 in after-hours trading, down 2.36% ($0.35) from the regular-session close of $ 14.59. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NPCE stock trading now?

NPCE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NPCE sit relative to its 52-week high and low?

Over the past 52 weeks, NPCE has traded between a low of $ 9.22 and a high of $ 19.60. At $ 14.23, the stock is positioned 48.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Neuropace, Inc. in?

Neuropace, Inc. (NPCE) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Neuropace, Inc.'s market capitalisation and where is it listed?

Neuropace, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 500.79M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NPCE valued in terms of P/E ratio and EPS?

NPCE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.56. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Neuropace, Inc. pay a dividend?

Neuropace, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.